Literature DB >> 3901267

Heterogeneity in hormone receptor status in primary and metastatic breast cancer.

C K Osborne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3901267

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  12 in total

1.  Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis.

Authors:  Lajos Pusztai; Giuseppe Viale; Catherine M Kelly; Clifford A Hudis
Journal:  Oncologist       Date:  2010-11-01

2.  Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.

Authors:  Min Yi; Thomas A Buchholz; Funda Meric-Bernstam; Isabelle Bedrosian; Rosa F Hwang; Merrick I Ross; Henry M Kuerer; Sheng Luo; Ana M Gonzalez-Angulo; Aman U Buzdar; W Fraser Symmans; Barry W Feig; Anthony Lucci; Eugene H Huang; Kelly K Hunt
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

3.  Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis.

Authors:  H M Scheres; A F De Goeij; M J Rousch; G G Hondius; D D Willebrand; A H Gijzen; F T Bosman
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

4.  Tissue microarrays for rapid linking of molecular changes to clinical endpoints.

Authors:  J Torhorst; C Bucher; J Kononen; P Haas; M Zuber; O R Köchli; F Mross; H Dieterich; H Moch; M Mihatsch; O P Kallioniemi; G Sauter
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

5.  Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader.

Authors:  Pedram Heidari; Francis Deng; Shadi A Esfahani; Alicia K Leece; Timothy M Shoup; Neil Vasdev; Umar Mahmood
Journal:  Clin Cancer Res       Date:  2015-01-21       Impact factor: 12.531

Review 6.  Endocrine therapy for advanced breast cancer: a review.

Authors:  H B Muss
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer.

Authors:  Christopher I Li; Janet R Daling; Peggy L Porter; Mei-Tzu C Tang; Kathleen E Malone
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

8.  Comparison of Predictive Immunohistochemical Marker Expression of Primary Breast Cancer and Paired Distant Metastasis using Surgical Material: A Practice-Based Study.

Authors:  Janina Kulka; Borbála Székely; Lilla V Lukács; Orsolya Kiss; Anna-Mária Tőkés; Eszter Vincze; Eszter Turányi; János Fillinger; Zoltán Hanzély; Gabriella Arató; Miklós Szendrői; Balázs Győrffy; A Marcell Szász
Journal:  J Histochem Cytochem       Date:  2016-04       Impact factor: 2.479

9.  Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

Authors:  R B Clarke; I J Laidlaw; L J Jones; A Howell; E Anderson
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

10.  Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states.

Authors:  G R Rutteman; W Misdorp; M A Blankenstein; W E van den Brom
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.